TY - JOUR
T1 - Human Papillomavirus Vaccinations During the COVID-19 Pandemic in Middle Schools in the Rio Grande Valley of Texas
AU - Rodriguez, Ana M.
AU - Do, Thuy Quynh N.
AU - Jibaja-Weiss, Maria L.
AU - Chen, Lu
AU - Schmeler, Kathleen M.
AU - Montealegre, Jane R.
AU - Kuo, Yong Fang
PY - 2022/9/1
Y1 - 2022/9/1
N2 - This quasi-experimental study (a community-based, physician-led human papillomavirus [HPV] education campaign and school-based vaccination program) followed 6481 students at eight Pharr-San Juan-Alamo Independent School District (Rio Grande Valley, Texas) middle schools between August 2016 and March 2021. We describe the successes and challenges experienced during the COVID-19 pandemic. HPV vaccine initiation and completion rates increased 1.29-fold and 1.47-fold, respectively, between June 2019 and March 2021. Between March 2020 and March 2021, 268 HPV vaccine doses were provided through 24 school-based interventions. Our program continued successes seen in increasing HPV vaccination rates and reducing possible HPV-associated cancers. (Am J Public Health. 2022;112(9):1269-1272. https://doi.org/10.2105/AJPH.2022.306970).
AB - This quasi-experimental study (a community-based, physician-led human papillomavirus [HPV] education campaign and school-based vaccination program) followed 6481 students at eight Pharr-San Juan-Alamo Independent School District (Rio Grande Valley, Texas) middle schools between August 2016 and March 2021. We describe the successes and challenges experienced during the COVID-19 pandemic. HPV vaccine initiation and completion rates increased 1.29-fold and 1.47-fold, respectively, between June 2019 and March 2021. Between March 2020 and March 2021, 268 HPV vaccine doses were provided through 24 school-based interventions. Our program continued successes seen in increasing HPV vaccination rates and reducing possible HPV-associated cancers. (Am J Public Health. 2022;112(9):1269-1272. https://doi.org/10.2105/AJPH.2022.306970).
UR - http://www.scopus.com/inward/record.url?scp=85136908929&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85136908929&partnerID=8YFLogxK
U2 - 10.2105/AJPH.2022.306970
DO - 10.2105/AJPH.2022.306970
M3 - Article
C2 - 35862887
AN - SCOPUS:85136908929
SN - 0090-0036
VL - 112
SP - 1269
EP - 1272
JO - American Journal of Public Health
JF - American Journal of Public Health
IS - 9
ER -